Xilio Therapeutics, Inc. (XLO)
NASDAQ · Healthcare
Xilio Therapeutics, Inc. annual/quarterly total liabilities history from 2024 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Xilio Therapeutics, Inc. total liabilities for the quarter ending December 31, 2025 were 119.4M, a 123.30% increase year-over-year.
- Xilio Therapeutics, Inc. total liabilities for 2025 were 119.4M, a 123.30% increase from 2024.
- Xilio Therapeutics, Inc. total liabilities for 2024 were 53.5M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Xilio Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $119 |
| 2024 | $53 |
| Xilio Therapeutics, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $119 |
| 2024-12-31 | $53 |
Xilio Therapeutics, Inc. Total Liabilities — FAQ
Xilio Therapeutics, Inc. (XLO) total liabilities over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XLO's total liabilities history?
The chart and table above show Xilio Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.